These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8718575)

  • 41. Mobilizing peptides in immunity.
    Nat Chem Biol; 2013 Dec; 9(12):747. PubMed ID: 24231605
    [No Abstract]   [Full Text] [Related]  

  • 42. Mucosal immunity and vaccines.
    Holmgren J; Czerkinsky C
    Nat Med; 2005 Apr; 11(4 Suppl):S45-53. PubMed ID: 15812489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases.
    Qu C; Brinck-Jensen NS; Zang M; Chen K
    Int J Infect Dis; 2014 Feb; 19():1-5. PubMed ID: 24216295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.
    Klinman DM; Klaschik S; Sato T; Tross D
    Adv Drug Deliv Rev; 2009 Mar; 61(3):248-55. PubMed ID: 19272313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From plasmids to protection: a review of DNA vaccines against infectious diseases.
    Laddy DJ; Weiner DB
    Int Rev Immunol; 2006; 25(3-4):99-123. PubMed ID: 16818367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In this issue: Fine tuners of immunity and their role in infectious and non-infectious diseases.
    Kumar H; Bot A
    Int Rev Immunol; 2017 Sep; 36(5):257-258. PubMed ID: 29135341
    [No Abstract]   [Full Text] [Related]  

  • 47. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH
    Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The HLA complex and the pathogenesis of infectious diseases.
    Pollack MS; Rich RR
    J Infect Dis; 1985 Jan; 151(1):1-8. PubMed ID: 3855304
    [No Abstract]   [Full Text] [Related]  

  • 49. [Immunoreactivity of individuals in heterogenous populations and immunoprophylaxis of infectious diseases].
    Sokhin AA
    Vestn Akad Med Nauk SSSR; 1983; (5):60-4. PubMed ID: 6868806
    [No Abstract]   [Full Text] [Related]  

  • 50. High throughput genomic and proteomic technologies in the fight against infectious diseases.
    Tanca A; Deligios M; Addis MF; Uzzau S
    J Infect Dev Ctries; 2013 Mar; 7(3):182-90. PubMed ID: 23492995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and nature of infectious disease in patients treated with anti-TNF agents.
    Raychaudhuri SP; Nguyen CT; Raychaudhuri SK; Gershwin ME
    Autoimmun Rev; 2009 Dec; 9(2):67-81. PubMed ID: 19716440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What to expect of future vaccines?
    Morein B; Lövgren Bengtsson K; Villacres-Eriksson M
    Acta Vet Scand Suppl; 1996; 90():101-6. PubMed ID: 8996895
    [No Abstract]   [Full Text] [Related]  

  • 53. Bibliography. Current world literature. infectious diseases and immunization.
    Curr Opin Pediatr; 2004 Feb; 16(1):124-35. PubMed ID: 14971394
    [No Abstract]   [Full Text] [Related]  

  • 54. Vaccination and herd immunity to infectious diseases.
    Anderson RM; May RM
    Nature; 1985 Nov 28-Dec 4; 318(6044):323-9. PubMed ID: 3906406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [THE ENVIRONMENT AND AUTOIMMUNE DISEASES].
    Watad A; Amital H; Shoenfeld Y
    Harefuah; 2015 May; 154(5):308-11, 339. PubMed ID: 26168641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The prospects for an improvement in the immunoprophylaxis of infectious diseases among the troops].
    Mel'nichenko PI; Ogarkov PI; Ishkil'din MI
    Voen Med Zh; 1999 Jun; 320(6):43-8. PubMed ID: 10439715
    [No Abstract]   [Full Text] [Related]  

  • 57. Polyvalent vaccines: High-maintenance heroes.
    Schlingmann B; Castiglia KR; Stobart CC; Moore ML
    PLoS Pathog; 2018 Apr; 14(4):e1006904. PubMed ID: 29621336
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunology--risk management in the body].
    Kabelitz D
    Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1563-5. PubMed ID: 15965863
    [No Abstract]   [Full Text] [Related]  

  • 59. Human breast milk: current concepts of immunology and infectious diseases. Foreword.
    Dumont-Driscoll M
    Curr Probl Pediatr Adolesc Health Care; 2007 Jan; 37(1):5-6. PubMed ID: 17157244
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of infection in autoimmune disease.
    Siminovitch KA
    Semin Immunol; 1998 Feb; 10(1):1-3. PubMed ID: 9529650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.